Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 

Scion Joins Covid-19 Vaccine Corporation’s Effort To Make NZ Own Covid Vaccine Via Unique Local Tech

Scion has partnered with New Zealand’s most experienced group of vaccine producers in the effort to produce a Covid-19 vaccine in New Zealand, for New Zealanders and the world.

Scion’s biotechnology pilot plant is critical to Covid-19 Vaccine Corporation’s vaccine development. The facility will allow CVC to grow its vaccine-producing bacteria at scale, making vaccine materials for testing purposes.

“Working with Scion will allow CVC to accelerate development and put us on a fast-track towards manufacturing and testing our Covid-19 vaccine. We really appreciate how Dr Lloyd-Jones’ team and Scion have moved to expedite our work; it’s another example of Kiwis pulling together and doing what they can to fight this dangerous disease,” says CVC’s Chief Scientific Officer, Dr Andy Herbert.

clockwise from front left: Taryn Saggese (Scion), Gareth Lloyd-Jones (Scion), David Hooks (Scion), Christophe Collet (Scion),  Andy Hollings (CVC), Alyesha Candy (Scion), Mark West (Scion), Sumanth Ranganathan (Scion)

CVC’s intended vaccine differs from other vaccine candidates for its unique biobead technology that it licensed from New Zealand company, Polybatics. It is currently working towards making small volumes of these vaccine-producing bacteria at the University of Auckland.

Its method includes making biobeads coated with carefully chosen components of the SARS-Cov-2 virus. The biobeads and coating are simultaneously manufactured inside bacteria which is an efficient method of production for a vaccine that the company expects to be both safe while offering broad immune coverage in humans.

These biobeads are grown at scale and purified at Scion’s specialised facility, where they will be produced as a test vaccine suitable for various testing purposes.

“Scion is delighted to assist in the development of CVC’s COVID-19 vaccine. With our fermentation capability and expertise in producing customised biopolymers, the Scion team will be able to produce vaccine materials for preclinical testing.”

“Scion has experience in producing bioplastic materials that are the main component of Polybatics’ biobeads technology that CVC is adapting for vaccine production,” says Dr Gareth Lloyd-Jones, Science Leader Biotransformation at Scion.

If testing is successful, CVC will manufacture more biobead vaccines for human trials using Good Manufacturing Practice, which requires stringent and traceable protocols.

CVC’s partners include the University of Auckland, Fonterra, Callaghan Innovation, Ardigen, and now Scion.

ABOUT CVC

CVC is made up of a group of lifelong biotech experts:

Dr Robert Feldman - a serial biotech entrepreneur and medical doctor with vaccine experience.

Dr Andy Herbert - a pharmaceutical development and manufacturing expert.

Tara Creaven-Capasso - a regulatory, quality and biotech expert with extensive international experience.

Helen Teale - a global clinical trial management expert.

Jeff Douglas – Managing director of Douglas Pharmaceuticals.

To date, the company has raised a million dollars in private company funding, and $488,000 in government funding.

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Statistics New Zealand: COVID-19 Sees Record 12.2 Percent Fall In New Zealand’s Economy

Gross domestic product (GDP) fell by 12.2 percent in the June 2020 quarter, the largest quarterly fall recorded since the current series began in 1987, as the COVID-19 restrictions in place through the quarter impacted economic activity, Stats NZ said ... More>>

ALSO:

Climate: Scientists Release ‘Blueprint’ To Save Critical Ecosystems And Stabilize The Earth’s Climate

A group of scientists and experts produced the first comprehensive global-scale analysis of terrestrial areas essential for biodiversity and climate resilience, totaling 50.4% of the Earth's land. The report was published in Science Advances ... More>>

ALSO:

MPI: Independent Review Launched Into Assurances For Safe Transport Of Livestock By Sea

The Ministry for Primary Industries (MPI) has launched an independent review of the assurances it receives for the safe transport of livestock by sea. MPI Director-General Ray Smith says Mike Heron QC has been appointed to lead the review, which is expected ... More>>

ALSO:


Computers: New Zealand PC Market Grows Nearly 40% Due To Work From Home Demand

COVID-19 had large impacts on demand for PCs as businesses prepared for lockdowns by purchasing notebooks to mobilise their workforce. In the second quarter of 2020, New Zealand's Traditional PC market experienced a 39.7% year-on-year (YoY) growth ... More>>

ALSO:

Mediaworks: Reaches Agreement To Sell TV Operations To Discovery, Inc.

New Zealand’s largest independent commercial broadcaster MediaWorks and the global leader of real-life entertainment Discovery Inc. (“Discovery”) are pleased to announce they have reached a binding agreement regarding the sale of MediaWorks’ ... More>>

ALSO:

Ministry of Health: Public Transport Distancing Requirements Relaxed

Physical distancing requirements on public transport have been reviewed by the Ministry of Health to determine whether they are still required at Alert Level 2 (or below). The Ministry’s assessment is that mandatory face covering and individuals tracking ... More>>

ALSO:

NZHIA: New Zealand Hemp Industry Set To Generate $2 Billion Per Annum And Create 20,000 Jobs

A new report says a fully enabled hemp industry could generate $2 billion in income for New Zealand by 2030, while also creating thousands of new jobs. Written by industry strategist Dr Nick Marsh, the report has prompted calls from the New Zealand Hemp ... More>>

ALSO:

Stats NZ: One In 14 Employed People Report High Risk Of Losing Jobs

About one in 14 workers say they expect to lose their job or business by mid-2021, Stats NZ said today. A survey of employed people in the June 2020 quarter showed 7 percent felt there was a high or almost certain chance of losing their job or business ... More>>

ASB Quarterly Economic Forecast: NZ Economy Doing Better Than Expected, But Challenges Remain

August lockdown estimated to have shaved 8% off NZ’s weekly GDP, and 0.5% off annual GDP Economy now expected to shrink 5% (year-on-year) by end of 2020 Unemployment rate now expected to peak at 7.2% The latest ASB Quarterly Economic Forecast is less ... More>>

ALSO:

SAFE: Live Export Ship Carrying 5,800 New Zealand Cows Goes Missing In East China Sea

Livestock carrier Gulf Livestock 1 sent a distress signal at 4:45am NZT yesterday in the East China Sea. The area is affected by Typhoon Maysak. At 4pm a patrol plane spotted a lifeboat - with no people in it - and a man in lifejacket nearby. The ship ... More>>

ALSO:

FMA: Kiwisaver Fees Don't Match Performance

The Financial Markets Authority (FMA) today published an independent report into the passive and active investment management styles [i] used by KiwiSaver providers. The FMA commissioned MyFiduciary to test the extent that KiwiSaver providers were ... More>>